Hub 2 - Vienna/Nashville/Berlin
This hub was founded in September 2023 and focusses on reviewing preprints in the area of immunology, inflammation and immunogenetics:
Medical University of Vienna (Vienna, Austria)
Vanderbilt University (Nashville, USA)
Max-Delbrück Center Berlin (Berlin, Germany)
This hub consists of a strong community of researchers focussing on immunology, immunometabolism, metabolism, immunogenetics and inflammation. Together, this hub reviews one preprint per week in a collaborative and community-based setting in their area of expertise.
He is co-founder of the Preprint Club Initiative.
Dörte Symmank is a Ph.D. student at Weninger Lab at the Medical University of Vienna. Her research primarily explores the reactions of immune cells, especially granulocytes, in inflammatory skin diseases and infections using multiphoton imaging and scSeq.
Teresa Neuwirth is a PhD student in the Stary lab at the Center for Molecular Medicine in Vienna, Austria where her work focuses on regulatory T cell metabolism during chronic inflammation. She is also vice-president of the Next Generation Immunologists Austria.
Jeffrey Rathmell is a Professor in the Department of Pathology, Microbiology, and Immunology. His research focuses on T cell immunometabolism in cancer and inflammatory diseases.
Danyvid Olivares-Villagomez is an Assistant Professor of Pathology, Microbiology & Immunology and Vanderbilt University Medical Center. His research focuses on mucosal immunology, with special emphasis on the biology lymphocytes dwelling in the intestinal epithelium.
Deborah Gil is a PhD student in the Janet Markle Lab at Vanderbilt University Medical Center. She studies inborn errors of immunity with a particular interest in the role of linear ubiquitin in immune signaling.
Kelsey Voss is a postdoctoral fellow at Vanderbilt University Medical Center in the lab of Jeff Rathmell. She studies T cell metabolism in inflammatory and autoimmune diseases and is especially interested in iron metabolism.
Alisa Iakupova is a PhD student in the Young-Ae Lee group at the Max Delbrück Center for Molecular Medicine in Berlin. Her research aims to understanding how food allergies can resolve spontaneously or persist through a lifetime.
Institutional Partner: Medical University of Vienna
The Medical University of Vienna is a leading medical center. The individual institutes, centers, departments and clinics thereby form an inseparable unity of education, research and patient care. The research at the Medical University of Vienna focusses on immunology, cancer research, neuroscience, cardiovascular medicine and medical imaging.
Our mission would not not be achievable without reliable partners that support the initiative and are crucial to the success of the cross-institutional immunology preprint journal club.
Institutional Partner: Vanderbilt University - Nashville
Vanderbilt University Medical Center (VUMC) is the largest comprehensive research, teaching and patient care health system in the Mid-South region, with the highest ranked adult and children’s hospitals in the Southeast by U.S. News & World Report. Based in Nashville, Tennessee, VUMC sees over 3 million patient visits per year in over 200 ambulatory locations, performs 85,000 surgical operations and discharges 75,000 inpatients from its main-campus adult, children’s, psychiatric and rehabilitation hospitals and three regional community hospitals. The Medical Center is the largest non-governmental employer of Middle Tennesseans, with nearly 40,000 staff, including more than 3,000 physicians, advanced practice nurses and scientists appointed to the Vanderbilt University faculty.
Communications Partner: Genes & Immunity
Genes & Immunity is a bimonthly journal published by Nature, part of Springer Nature. The journal publishes articles focused on understanding how genetic, genomic and functional variations affect immune cells and the immune system. The editorial team is led by Prof. Abhishek Garg, who has a long trajectory in immune-oncology, and counts with the expertise of four associate editor, representative of the four main topics covered by G&I: Clinical Immunology, Single-cell omics, Translational Immunology and Immunogenetics. In addition, we want to better serve the emerging needs and expectations of the research community by including among our publications, short highlights of yet-to-be peer reviewed preprints in the field. For that we collaborate with the Preprint Club.
Institutional Partner: Max-Delbrück Center Berlin
The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) is a leading research institution located in Berlin, Germany. It was founded in 1992 and is named after the German-American physicist and biologist Max Delbrück, who was awarded the Nobel Prize in Physiology or Medicine in 1969 for his pioneering work in molecular genetics. The MDC's mission is to study molecular mechanisms to understand the origins of diseases and to develop new therapies. The center focuses on cardiovascular and metabolic diseases, cancer, neurological diseases, and diseases of the immune system. The MDC combines basic research with clinical research to ensure that discoveries in the laboratory can be translated into clinical applications as quickly as possible. The MDC collaborates with various institutions, hospitals, and universities, both nationally and internationally, to promote interdisciplinary and translational research. It is part of the Helmholtz Association, Germany's largest scientific organization.The MDC has state-of-the-art facilities and employs a diverse group of scientists from various disciplines, making it a hub for innovative research in the field of molecular medicine.